GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
68.77 USD
-0.46 (-0.66%)
At close:
68.68 USD
-0.09 (-0.13%)
After Hours:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- In the past year GEHC was profitable.
- GEHC had a positive operating cash flow in the past year.
- GEHC had positive earnings in each of the past 5 years.
- Each year in the past 5 years GEHC had a positive operating cash flow.
1.2 Ratios
- GEHC's Return On Assets of 5.65% is amongst the best of the industry. GEHC outperforms 81.91% of its industry peers.
- The Return On Equity of GEHC (20.09%) is better than 94.68% of its industry peers.
- GEHC has a Return On Invested Capital of 7.81%. This is amongst the best in the industry. GEHC outperforms 81.91% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 9.36%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- GEHC has a Profit Margin of 10.11%. This is amongst the best in the industry. GEHC outperforms 83.51% of its industry peers.
- In the last couple of years the Profit Margin of GEHC has declined.
- GEHC's Operating Margin of 13.40% is amongst the best of the industry. GEHC outperforms 80.85% of its industry peers.
- In the last couple of years the Operating Margin of GEHC has declined.
- GEHC's Gross Margin of 39.98% is on the low side compared to the rest of the industry. GEHC is outperformed by 65.96% of its industry peers.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- GEHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, GEHC has less shares outstanding
- Compared to 5 years ago, GEHC has more shares outstanding
- GEHC has about the same debt/assets ratio as last year.
2.2 Solvency
- An Altman-Z score of 1.83 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 1.83, GEHC is doing good in the industry, outperforming 60.11% of the companies in the same industry.
- The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
- GEHC has a Debt to FCF ratio of 6.67. This is in the better half of the industry: GEHC outperforms 75.53% of its industry peers.
- A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
- GEHC has a Debt to Equity ratio of 0.92. This is in the lower half of the industry: GEHC underperforms 72.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.83 |
ROIC/WACC0.76
WACC10.26%
2.3 Liquidity
- GEHC has a Current Ratio of 1.37. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.37, GEHC is not doing good in the industry: 78.19% of the companies in the same industry are doing better.
- GEHC has a Quick Ratio of 1.13. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- GEHC has a worse Quick ratio (1.13) than 72.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 2.00% over the past year.
- GEHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.63% yearly.
- The Revenue has been growing slightly by 4.85% in the past year.
- The Revenue has been growing slightly by 3.74% on average over the past years.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
3.2 Future
- Based on estimates for the next years, GEHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.20% on average per year.
- GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- GEHC is valuated correctly with a Price/Earnings ratio of 15.02.
- 86.70% of the companies in the same industry are more expensive than GEHC, based on the Price/Earnings ratio.
- GEHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.75.
- The Price/Forward Earnings ratio is 13.31, which indicates a correct valuation of GEHC.
- Based on the Price/Forward Earnings ratio, GEHC is valued cheaply inside the industry as 89.36% of the companies are valued more expensively.
- GEHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.02 | ||
| Fwd PE | 13.31 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 88.83% of the companies listed in the same industry.
- 86.17% of the companies in the same industry are more expensive than GEHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.83 | ||
| EV/EBITDA | 11.04 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.17
PEG (5Y)N/A
EPS Next 2Y11.37%
EPS Next 3Y11.08%
5. GEHC Dividend Analysis
5.1 Amount
- GEHC has a yearly dividend return of 0.20%, which is pretty low.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.24. GEHC pays more dividend than 89.36% of the companies in the same industry.
- With a Dividend Yield of 0.20, GEHC pays less dividend than the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
GEHC Fundamentals: All Metrics, Ratios and Statistics
68.77
-0.46 (-0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-27 2026-04-27
Inst Owners93.29%
Inst Owner Change12.35%
Ins Owners0.3%
Ins Owner Change0.63%
Market Cap31.34B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target94.98 (38.11%)
Short Float %2.43%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.98%
PT rev (3m)3.79%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)4.38%
EPS NY rev (1m)2.9%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.02 | ||
| Fwd PE | 13.31 | ||
| P/S | 1.52 | ||
| P/FCF | 20.83 | ||
| P/OCF | 15.77 | ||
| P/B | 3.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.04 |
EPS(TTM)4.58
EY6.66%
EPS(NY)5.17
Fwd EY7.52%
FCF(TTM)3.3
FCFY4.8%
OCF(TTM)4.36
OCFY6.34%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.17
PEG (5Y)N/A
Graham Number48.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.83 |
F-Score4
WACC10.26%
ROIC/WACC0.76
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.
Can you provide the dividend sustainability for GEHC stock?
The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.